Search research articles
Contact Us
Filters
Showing results (141-150 of 386) with videos related to
Page
of 39
Sort By:
Journal of Cellular Biochemistry
|
May 10, 2005
MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?
Paul Dent, Adly Yacoub, Steven Grant, et al.
Biochemical Pharmacology
|
June 6, 2003
Enforced expression of the tumor suppressor p53 renders human leukemia cells (U937) more sensitive to 1-[beta-D-arabinofuranosyl]cytosine (ara-C)-induced apoptosis
Roy H Decker, Jay Levin, Lora B Kramer, et al.
Hematology Reports
|
February 22, 2023
Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Clinical Lymphoma
|
January 11, 2003
Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma
John D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2005
The farnesyltransferase inhibitor L744832 potentiates UCN-01-induced apoptosis in human multiple myeloma cells
Xin-Yan Pei, Yun Dai, Mohamed Rahmani, et al.
The Journal of Reproductive Medicine
|
December 1, 2004
Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study
Ronald W Jones, Lynn Sadler, Steven Grant, et al.
Blood
|
February 1, 2007
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation
Yun Dai, Payal Khanna, Shuang Chen, et al.
British Journal of Haematology
|
January 31, 2013
The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
Girija Dasmahapatra, Hiral Patel, Paul Dent, et al.
Molecular Cancer Therapeutics
|
August 9, 2014
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs
Laurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Cancer Biology & Therapy
|
September 20, 2012
OSU-03012 interacts with lapatinib to kill brain cancer cells
Laurence Booth, Nichola Cruickshanks, Thomas Ridder, et al.
Page
of 39
Search research articles
Search
Showing results (141-150 of 386) with videos related to
Sort By:
Page
of 39
Journal of Cellular Biochemistry
|
May 10, 2005
MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?
Paul Dent, Adly Yacoub, Steven Grant, et al.
Biochemical Pharmacology
|
June 6, 2003
Enforced expression of the tumor suppressor p53 renders human leukemia cells (U937) more sensitive to 1-[beta-D-arabinofuranosyl]cytosine (ara-C)-induced apoptosis
Roy H Decker, Jay Levin, Lora B Kramer, et al.
Hematology Reports
|
February 22, 2023
Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Clinical Lymphoma
|
January 11, 2003
Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma
John D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2005
The farnesyltransferase inhibitor L744832 potentiates UCN-01-induced apoptosis in human multiple myeloma cells
Xin-Yan Pei, Yun Dai, Mohamed Rahmani, et al.
The Journal of Reproductive Medicine
|
December 1, 2004
Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study
Ronald W Jones, Lynn Sadler, Steven Grant, et al.
Blood
|
February 1, 2007
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation
Yun Dai, Payal Khanna, Shuang Chen, et al.
British Journal of Haematology
|
January 31, 2013
The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
Girija Dasmahapatra, Hiral Patel, Paul Dent, et al.
Molecular Cancer Therapeutics
|
August 9, 2014
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs
Laurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Cancer Biology & Therapy
|
September 20, 2012
OSU-03012 interacts with lapatinib to kill brain cancer cells
Laurence Booth, Nichola Cruickshanks, Thomas Ridder, et al.
Page
of 39